GO:0008150 | biological_process | 61.62% (114/185) | 0.93 | 0.0 | 0.0 |
GO:0009987 | cellular process | 45.41% (84/185) | 1.23 | 0.0 | 0.0 |
GO:0005488 | binding | 57.84% (107/185) | 0.88 | 0.0 | 0.0 |
GO:0051649 | establishment of localization in cell | 8.65% (16/185) | 3.59 | 0.0 | 0.0 |
GO:0046907 | intracellular transport | 8.65% (16/185) | 3.6 | 0.0 | 0.0 |
GO:0005515 | protein binding | 31.35% (58/185) | 1.43 | 0.0 | 0.0 |
GO:0051641 | cellular localization | 9.19% (17/185) | 3.21 | 0.0 | 0.0 |
GO:0005524 | ATP binding | 21.08% (39/185) | 1.73 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 14.05% (26/185) | 2.12 | 0.0 | 0.0 |
GO:0030554 | adenyl nucleotide binding | 22.16% (41/185) | 1.54 | 0.0 | 0.0 |
GO:0035639 | purine ribonucleoside triphosphate binding | 21.08% (39/185) | 1.6 | 0.0 | 0.0 |
GO:0016192 | vesicle-mediated transport | 7.03% (13/185) | 3.4 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 70.81% (131/185) | 0.53 | 0.0 | 0.0 |
GO:0032559 | adenyl ribonucleotide binding | 21.08% (39/185) | 1.54 | 0.0 | 0.0 |
GO:0097367 | carbohydrate derivative binding | 22.16% (41/185) | 1.46 | 0.0 | 0.0 |
GO:0017076 | purine nucleotide binding | 22.16% (41/185) | 1.42 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 29.19% (54/185) | 1.15 | 0.0 | 0.0 |
GO:1901363 | heterocyclic compound binding | 23.24% (43/185) | 1.35 | 0.0 | 0.0 |
GO:0036094 | small molecule binding | 23.24% (43/185) | 1.34 | 0.0 | 0.0 |
GO:0032555 | purine ribonucleotide binding | 21.08% (39/185) | 1.42 | 0.0 | 0.0 |
GO:0032553 | ribonucleotide binding | 21.08% (39/185) | 1.4 | 0.0 | 1e-06 |
GO:1901265 | nucleoside phosphate binding | 22.16% (41/185) | 1.34 | 0.0 | 1e-06 |
GO:0000166 | nucleotide binding | 22.16% (41/185) | 1.34 | 0.0 | 1e-06 |
GO:0043170 | macromolecule metabolic process | 26.49% (49/185) | 1.18 | 0.0 | 1e-06 |
GO:0051179 | localization | 14.05% (26/185) | 1.73 | 0.0 | 2e-06 |
GO:0033036 | macromolecule localization | 5.95% (11/185) | 3.05 | 0.0 | 2e-06 |
GO:0070727 | cellular macromolecule localization | 5.95% (11/185) | 3.05 | 0.0 | 2e-06 |
GO:0008104 | protein localization | 5.95% (11/185) | 3.05 | 0.0 | 2e-06 |
GO:0006886 | intracellular protein transport | 4.86% (9/185) | 3.47 | 0.0 | 3e-06 |
GO:0044238 | primary metabolic process | 31.35% (58/185) | 0.96 | 0.0 | 4e-06 |
GO:0006810 | transport | 13.51% (25/185) | 1.71 | 0.0 | 4e-06 |
GO:0043168 | anion binding | 21.08% (39/185) | 1.25 | 0.0 | 5e-06 |
GO:0051234 | establishment of localization | 13.51% (25/185) | 1.69 | 0.0 | 5e-06 |
GO:0015031 | protein transport | 5.41% (10/185) | 3.11 | 0.0 | 5e-06 |
GO:0016459 | myosin complex | 2.16% (4/185) | 5.83 | 1e-06 | 1e-05 |
GO:0071702 | organic substance transport | 7.03% (13/185) | 2.48 | 1e-06 | 1.3e-05 |
GO:0045184 | establishment of protein localization | 5.41% (10/185) | 2.95 | 1e-06 | 1.3e-05 |
GO:0071704 | organic substance metabolic process | 31.89% (59/185) | 0.87 | 1e-06 | 1.8e-05 |
GO:0016043 | cellular component organization | 8.11% (15/185) | 2.2 | 1e-06 | 1.9e-05 |
GO:0051020 | GTPase binding | 2.16% (4/185) | 5.53 | 1e-06 | 2.2e-05 |
GO:0031267 | small GTPase binding | 2.16% (4/185) | 5.53 | 1e-06 | 2.2e-05 |
GO:0044877 | protein-containing complex binding | 3.78% (7/185) | 3.62 | 2e-06 | 2.6e-05 |
GO:0003774 | cytoskeletal motor activity | 3.24% (6/185) | 4.02 | 2e-06 | 2.8e-05 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 7.57% (14/185) | 2.24 | 2e-06 | 2.8e-05 |
GO:0140657 | ATP-dependent activity | 7.03% (13/185) | 2.31 | 3e-06 | 3.6e-05 |
GO:0140096 | catalytic activity, acting on a protein | 16.76% (31/185) | 1.3 | 3e-06 | 3.8e-05 |
GO:0005575 | cellular_component | 21.62% (40/185) | 1.1 | 3e-06 | 3.8e-05 |
GO:0140535 | intracellular protein-containing complex | 4.32% (8/185) | 3.18 | 3e-06 | 4.2e-05 |
GO:0030117 | membrane coat | 2.7% (5/185) | 4.42 | 4e-06 | 4.5e-05 |
GO:0019538 | protein metabolic process | 18.92% (35/185) | 1.19 | 4e-06 | 4.5e-05 |
GO:0036211 | protein modification process | 14.59% (27/185) | 1.39 | 4e-06 | 5.2e-05 |
GO:0008152 | metabolic process | 32.43% (60/185) | 0.8 | 4e-06 | 5.2e-05 |
GO:0071840 | cellular component organization or biogenesis | 8.11% (15/185) | 2.02 | 5e-06 | 6e-05 |
GO:0006996 | organelle organization | 4.86% (9/185) | 2.81 | 6e-06 | 7.1e-05 |
GO:1990234 | transferase complex | 3.78% (7/185) | 3.32 | 7e-06 | 7.7e-05 |
GO:0043412 | macromolecule modification | 15.14% (28/185) | 1.32 | 7e-06 | 7.7e-05 |
GO:0016482 | cytosolic transport | 1.62% (3/185) | 6.11 | 9e-06 | 8.7e-05 |
GO:0005049 | nuclear export signal receptor activity | 1.62% (3/185) | 6.11 | 9e-06 | 8.7e-05 |
GO:0042147 | retrograde transport, endosome to Golgi | 1.62% (3/185) | 6.11 | 9e-06 | 8.7e-05 |
GO:0008094 | ATP-dependent activity, acting on DNA | 3.24% (6/185) | 3.67 | 8e-06 | 8.7e-05 |
GO:0016197 | endosomal transport | 2.16% (4/185) | 4.94 | 8e-06 | 8.8e-05 |
GO:0016787 | hydrolase activity | 16.76% (31/185) | 1.21 | 1e-05 | 9.4e-05 |
GO:1901564 | organonitrogen compound metabolic process | 21.08% (39/185) | 1.04 | 1e-05 | 9.4e-05 |
GO:1902493 | acetyltransferase complex | 2.16% (4/185) | 4.88 | 1e-05 | 9.5e-05 |
GO:0031248 | protein acetyltransferase complex | 2.16% (4/185) | 4.88 | 1e-05 | 9.5e-05 |
GO:0007015 | actin filament organization | 2.7% (5/185) | 4.12 | 1e-05 | 9.6e-05 |
GO:0044237 | cellular metabolic process | 23.78% (44/185) | 0.95 | 1.1e-05 | 9.9e-05 |
GO:0071705 | nitrogen compound transport | 5.41% (10/185) | 2.49 | 1.3e-05 | 0.000122 |
GO:0140326 | ATPase-coupled intramembrane lipid transporter activity | 1.62% (3/185) | 5.79 | 1.8e-05 | 0.000164 |
GO:0019899 | enzyme binding | 2.7% (5/185) | 3.94 | 1.9e-05 | 0.000168 |
GO:0097159 | organic cyclic compound binding | 30.81% (57/185) | 0.76 | 2.1e-05 | 0.000179 |
GO:0097435 | supramolecular fiber organization | 2.7% (5/185) | 3.92 | 2.1e-05 | 0.000179 |
GO:0140303 | intramembrane lipid transporter activity | 1.62% (3/185) | 5.65 | 2.5e-05 | 0.000212 |
GO:0015914 | phospholipid transport | 1.62% (3/185) | 5.53 | 3.3e-05 | 0.000277 |
GO:0051015 | actin filament binding | 2.16% (4/185) | 4.44 | 3.4e-05 | 0.000281 |
GO:0043167 | ion binding | 25.95% (48/185) | 0.83 | 3.5e-05 | 0.000286 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 12.43% (23/185) | 1.35 | 3.8e-05 | 0.000301 |
GO:0140142 | nucleocytoplasmic carrier activity | 1.62% (3/185) | 5.41 | 4.3e-05 | 0.000341 |
GO:0007010 | cytoskeleton organization | 2.7% (5/185) | 3.64 | 5.3e-05 | 0.000412 |
GO:0030131 | clathrin adaptor complex | 1.62% (3/185) | 5.3 | 5.5e-05 | 0.000421 |
GO:0006468 | protein phosphorylation | 10.27% (19/185) | 1.47 | 6.4e-05 | 0.000491 |
GO:0016310 | phosphorylation | 10.27% (19/185) | 1.45 | 7.7e-05 | 0.000578 |
GO:0006643 | membrane lipid metabolic process | 2.16% (4/185) | 4.1 | 8.7e-05 | 0.000642 |
GO:0008092 | cytoskeletal protein binding | 3.78% (7/185) | 2.75 | 9e-05 | 0.000648 |
GO:0004672 | protein kinase activity | 10.27% (19/185) | 1.43 | 8.9e-05 | 0.000649 |
GO:0051377 | mannose-ethanolamine phosphotransferase activity | 1.08% (2/185) | 6.94 | 8.7e-05 | 0.000649 |
GO:0009742 | brassinosteroid mediated signaling pathway | 1.62% (3/185) | 4.94 | 0.00012 | 0.000844 |
GO:0043401 | steroid hormone mediated signaling pathway | 1.62% (3/185) | 4.94 | 0.00012 | 0.000844 |
GO:0140097 | catalytic activity, acting on DNA | 3.24% (6/185) | 2.92 | 0.000151 | 0.001049 |
GO:0006796 | phosphate-containing compound metabolic process | 11.89% (22/185) | 1.24 | 0.000162 | 0.001114 |
GO:0005319 | lipid transporter activity | 1.62% (3/185) | 4.79 | 0.000167 | 0.001132 |
GO:0006793 | phosphorus metabolic process | 11.89% (22/185) | 1.24 | 0.000169 | 0.001135 |
GO:0030121 | AP-1 adaptor complex | 1.08% (2/185) | 6.53 | 0.000174 | 0.001155 |
GO:0030119 | AP-type membrane coat adaptor complex | 1.62% (3/185) | 4.72 | 0.000194 | 0.001247 |
GO:0000123 | histone acetyltransferase complex | 1.62% (3/185) | 4.72 | 0.000194 | 0.001247 |
GO:0000151 | ubiquitin ligase complex | 1.62% (3/185) | 4.72 | 0.000194 | 0.001247 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 3.24% (6/185) | 2.84 | 0.000209 | 0.001305 |
GO:0019941 | modification-dependent protein catabolic process | 3.24% (6/185) | 2.84 | 0.000209 | 0.001305 |
GO:0043632 | modification-dependent macromolecule catabolic process | 3.24% (6/185) | 2.84 | 0.000209 | 0.001305 |
GO:0004534 | 5'-3' RNA exonuclease activity | 1.08% (2/185) | 6.21 | 0.000289 | 0.001784 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 10.27% (19/185) | 1.3 | 0.000295 | 0.001805 |
GO:0048193 | Golgi vesicle transport | 2.16% (4/185) | 3.62 | 0.000322 | 0.001945 |
GO:0015748 | organophosphate ester transport | 1.62% (3/185) | 4.47 | 0.00033 | 0.001977 |
GO:0140104 | molecular carrier activity | 1.62% (3/185) | 4.41 | 0.000372 | 0.002205 |
GO:0051603 | proteolysis involved in protein catabolic process | 3.24% (6/185) | 2.68 | 0.000378 | 0.002218 |
GO:0030149 | sphingolipid catabolic process | 1.08% (2/185) | 5.94 | 0.000432 | 0.002469 |
GO:0046466 | membrane lipid catabolic process | 1.08% (2/185) | 5.94 | 0.000432 | 0.002469 |
GO:0046514 | ceramide catabolic process | 1.08% (2/185) | 5.94 | 0.000432 | 0.002469 |
GO:0016301 | kinase activity | 10.27% (19/185) | 1.24 | 0.000466 | 0.002639 |
GO:0006888 | endoplasmic reticulum to Golgi vesicle-mediated transport | 1.62% (3/185) | 4.25 | 0.000516 | 0.002895 |
GO:0000124 | SAGA complex | 1.08% (2/185) | 5.72 | 0.000603 | 0.003351 |
GO:0043227 | membrane-bounded organelle | 5.41% (10/185) | 1.81 | 0.000627 | 0.003425 |
GO:0043231 | intracellular membrane-bounded organelle | 5.41% (10/185) | 1.81 | 0.000627 | 0.003425 |
GO:0006139 | nucleobase-containing compound metabolic process | 9.19% (17/185) | 1.29 | 0.000637 | 0.003447 |
GO:0003779 | actin binding | 2.16% (4/185) | 3.34 | 0.000679 | 0.003645 |
GO:1903509 | liposaccharide metabolic process | 1.62% (3/185) | 4.11 | 0.000692 | 0.003651 |
GO:0006664 | glycolipid metabolic process | 1.62% (3/185) | 4.11 | 0.000692 | 0.003651 |
GO:0006508 | proteolysis | 5.95% (11/185) | 1.69 | 0.000704 | 0.00368 |
GO:0032774 | RNA biosynthetic process | 3.24% (6/185) | 2.49 | 0.000748 | 0.003878 |
GO:0016070 | RNA metabolic process | 6.49% (12/185) | 1.58 | 0.000754 | 0.003879 |
GO:0008409 | 5'-3' exonuclease activity | 1.08% (2/185) | 5.53 | 0.000801 | 0.004084 |
GO:0140098 | catalytic activity, acting on RNA | 4.32% (8/185) | 2.03 | 0.000837 | 0.004235 |
GO:0016887 | ATP hydrolysis activity | 3.78% (7/185) | 2.15 | 0.00108 | 0.005417 |
GO:0009056 | catabolic process | 5.41% (10/185) | 1.69 | 0.001183 | 0.005886 |
GO:0090304 | nucleic acid metabolic process | 7.57% (14/185) | 1.36 | 0.001229 | 0.00602 |
GO:0003824 | catalytic activity | 34.59% (64/185) | 0.5 | 0.001228 | 0.006064 |
GO:0005794 | Golgi apparatus | 1.08% (2/185) | 5.21 | 0.001278 | 0.006066 |
GO:0001882 | nucleoside binding | 1.08% (2/185) | 5.21 | 0.001278 | 0.006066 |
GO:0032549 | ribonucleoside binding | 1.08% (2/185) | 5.21 | 0.001278 | 0.006066 |
GO:0030127 | COPII vesicle coat | 1.08% (2/185) | 5.21 | 0.001278 | 0.006066 |
GO:0140658 | ATP-dependent chromatin remodeler activity | 1.62% (3/185) | 3.79 | 0.001336 | 0.006292 |
GO:0005634 | nucleus | 4.32% (8/185) | 1.9 | 0.001484 | 0.006936 |
GO:1902494 | catalytic complex | 3.78% (7/185) | 2.05 | 0.001611 | 0.007472 |
GO:0046483 | heterocycle metabolic process | 9.19% (17/185) | 1.16 | 0.001729 | 0.00796 |
GO:0070461 | SAGA-type complex | 1.08% (2/185) | 4.94 | 0.001861 | 0.008506 |
GO:0016579 | protein deubiquitination | 1.62% (3/185) | 3.62 | 0.001881 | 0.008533 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4.86% (9/185) | 1.69 | 0.00207 | 0.009322 |
GO:0004843 | cysteine-type deubiquitinase activity | 1.62% (3/185) | 3.56 | 0.002132 | 0.009397 |
GO:0070646 | protein modification by small protein removal | 1.62% (3/185) | 3.56 | 0.002132 | 0.009397 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 4.86% (9/185) | 1.69 | 0.002125 | 0.009499 |
GO:0005669 | transcription factor TFIID complex | 1.08% (2/185) | 4.83 | 0.002192 | 0.009523 |
GO:0006672 | ceramide metabolic process | 1.08% (2/185) | 4.83 | 0.002192 | 0.009523 |
GO:0006725 | cellular aromatic compound metabolic process | 9.19% (17/185) | 1.12 | 0.002234 | 0.00964 |
GO:0045324 | late endosome to vacuole transport | 1.08% (2/185) | 4.72 | 0.002548 | 0.010917 |
GO:0009057 | macromolecule catabolic process | 3.24% (6/185) | 2.13 | 0.002664 | 0.011335 |
GO:0098796 | membrane protein complex | 3.24% (6/185) | 2.1 | 0.002934 | 0.012313 |
GO:0006665 | sphingolipid metabolic process | 1.08% (2/185) | 4.62 | 0.002929 | 0.01238 |
GO:1901360 | organic cyclic compound metabolic process | 9.19% (17/185) | 1.08 | 0.002979 | 0.012418 |
GO:0101005 | deubiquitinase activity | 1.62% (3/185) | 3.25 | 0.003885 | 0.015979 |
GO:0006869 | lipid transport | 1.62% (3/185) | 3.25 | 0.003885 | 0.015979 |
GO:0051169 | nuclear transport | 1.62% (3/185) | 3.23 | 0.004077 | 0.016658 |
GO:0044242 | cellular lipid catabolic process | 1.08% (2/185) | 4.36 | 0.004223 | 0.017143 |
GO:0007017 | microtubule-based process | 2.16% (4/185) | 2.61 | 0.004337 | 0.017491 |
GO:0019783 | ubiquitin-like protein peptidase activity | 1.62% (3/185) | 3.18 | 0.004478 | 0.01794 |
GO:0005875 | microtubule associated complex | 1.08% (2/185) | 4.28 | 0.004703 | 0.018367 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 1.08% (2/185) | 4.28 | 0.004703 | 0.018367 |
GO:0005643 | nuclear pore | 1.08% (2/185) | 4.28 | 0.004703 | 0.018367 |
GO:0003678 | DNA helicase activity | 1.08% (2/185) | 4.28 | 0.004703 | 0.018367 |
GO:0034450 | ubiquitin-ubiquitin ligase activity | 0.54% (1/185) | 7.53 | 0.005421 | 0.019559 |
GO:0030906 | retromer, cargo-selective complex | 0.54% (1/185) | 7.53 | 0.005421 | 0.019559 |
GO:0032456 | endocytic recycling | 0.54% (1/185) | 7.53 | 0.005421 | 0.019559 |
GO:0010252 | obsolete auxin homeostasis | 0.54% (1/185) | 7.53 | 0.005421 | 0.019559 |
GO:1990745 | EARP complex | 0.54% (1/185) | 7.53 | 0.005421 | 0.019559 |
GO:0034502 | protein localization to chromosome | 0.54% (1/185) | 7.53 | 0.005421 | 0.019559 |
GO:0061780 | mitotic cohesin loading | 0.54% (1/185) | 7.53 | 0.005421 | 0.019559 |
GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA | 0.54% (1/185) | 7.53 | 0.005421 | 0.019559 |
GO:0071168 | protein localization to chromatin | 0.54% (1/185) | 7.53 | 0.005421 | 0.019559 |
GO:0008240 | tripeptidyl-peptidase activity | 0.54% (1/185) | 7.53 | 0.005421 | 0.019559 |
GO:0016236 | macroautophagy | 0.54% (1/185) | 7.53 | 0.005421 | 0.019559 |
GO:0071921 | cohesin loading | 0.54% (1/185) | 7.53 | 0.005421 | 0.019559 |
GO:0016780 | phosphotransferase activity, for other substituted phosphate groups | 1.08% (2/185) | 4.21 | 0.005207 | 0.020207 |
GO:0006505 | GPI anchor metabolic process | 1.08% (2/185) | 4.14 | 0.005735 | 0.020336 |
GO:0071985 | multivesicular body sorting pathway | 1.08% (2/185) | 4.14 | 0.005735 | 0.020336 |
GO:0006506 | GPI anchor biosynthetic process | 1.08% (2/185) | 4.14 | 0.005735 | 0.020336 |
GO:0016788 | hydrolase activity, acting on ester bonds | 5.41% (10/185) | 1.36 | 0.00604 | 0.021295 |
GO:0006914 | autophagy | 1.08% (2/185) | 4.07 | 0.006286 | 0.021548 |
GO:0061919 | process utilizing autophagic mechanism | 1.08% (2/185) | 4.07 | 0.006286 | 0.021548 |
GO:1905368 | peptidase complex | 1.08% (2/185) | 4.07 | 0.006286 | 0.021548 |
GO:0006497 | protein lipidation | 1.08% (2/185) | 4.07 | 0.006286 | 0.021548 |
GO:0034641 | cellular nitrogen compound metabolic process | 9.73% (18/185) | 0.94 | 0.00617 | 0.021631 |
GO:0006351 | DNA-templated transcription | 2.16% (4/185) | 2.45 | 0.006373 | 0.021726 |
GO:0016462 | pyrophosphatase activity | 4.32% (8/185) | 1.55 | 0.006461 | 0.021903 |
GO:0004721 | phosphoprotein phosphatase activity | 1.62% (3/185) | 2.92 | 0.00738 | 0.024884 |
GO:0070925 | organelle assembly | 1.08% (2/185) | 3.94 | 0.007458 | 0.025007 |
GO:0046488 | phosphatidylinositol metabolic process | 1.62% (3/185) | 2.9 | 0.007662 | 0.025554 |
GO:1901565 | organonitrogen compound catabolic process | 2.16% (4/185) | 2.32 | 0.008757 | 0.028893 |
GO:0030120 | vesicle coat | 1.08% (2/185) | 3.83 | 0.00872 | 0.028925 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 1.08% (2/185) | 3.77 | 0.009384 | 0.030313 |
GO:0010498 | proteasomal protein catabolic process | 1.08% (2/185) | 3.77 | 0.009384 | 0.030313 |
GO:0016896 | RNA exonuclease activity, producing 5'-phosphomonoesters | 1.08% (2/185) | 3.77 | 0.009384 | 0.030313 |
GO:0004532 | RNA exonuclease activity | 1.08% (2/185) | 3.77 | 0.009384 | 0.030313 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 3.24% (6/185) | 1.75 | 0.00948 | 0.030464 |
GO:0004134 | 4-alpha-glucanotransferase activity | 0.54% (1/185) | 6.53 | 0.010812 | 0.031919 |
GO:0016574 | histone ubiquitination | 0.54% (1/185) | 6.53 | 0.010812 | 0.031919 |
GO:0000938 | GARP complex | 0.54% (1/185) | 6.53 | 0.010812 | 0.031919 |
GO:0006513 | protein monoubiquitination | 0.54% (1/185) | 6.53 | 0.010812 | 0.031919 |
GO:0017040 | N-acylsphingosine amidohydrolase activity | 0.54% (1/185) | 6.53 | 0.010812 | 0.031919 |
GO:0032777 | piccolo histone acetyltransferase complex | 0.54% (1/185) | 6.53 | 0.010812 | 0.031919 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 0.54% (1/185) | 6.53 | 0.010812 | 0.031919 |
GO:0010390 | histone monoubiquitination | 0.54% (1/185) | 6.53 | 0.010812 | 0.031919 |
GO:0031417 | NatC complex | 0.54% (1/185) | 6.53 | 0.010812 | 0.031919 |
GO:0018206 | peptidyl-methionine modification | 0.54% (1/185) | 6.53 | 0.010812 | 0.031919 |
GO:0098876 | vesicle-mediated transport to the plasma membrane | 0.54% (1/185) | 6.53 | 0.010812 | 0.031919 |
GO:0019632 | shikimate metabolic process | 0.54% (1/185) | 6.53 | 0.010812 | 0.031919 |
GO:0009247 | glycolipid biosynthetic process | 1.08% (2/185) | 3.72 | 0.01007 | 0.032026 |
GO:1903047 | mitotic cell cycle process | 1.08% (2/185) | 3.72 | 0.01007 | 0.032026 |
GO:1901575 | organic substance catabolic process | 4.32% (8/185) | 1.43 | 0.010502 | 0.03306 |
GO:0008234 | cysteine-type peptidase activity | 2.16% (4/185) | 2.24 | 0.010478 | 0.033155 |
GO:0016042 | lipid catabolic process | 1.08% (2/185) | 3.62 | 0.011507 | 0.033489 |
GO:0007034 | vacuolar transport | 1.08% (2/185) | 3.62 | 0.011507 | 0.033489 |
GO:0006661 | phosphatidylinositol biosynthetic process | 1.08% (2/185) | 3.62 | 0.011507 | 0.033489 |
GO:0003682 | chromatin binding | 1.08% (2/185) | 3.67 | 0.010778 | 0.033755 |
GO:0016791 | phosphatase activity | 2.7% (5/185) | 1.88 | 0.011951 | 0.034457 |
GO:0140513 | nuclear protein-containing complex | 2.7% (5/185) | 1.88 | 0.011951 | 0.034457 |
GO:0043226 | organelle | 5.95% (11/185) | 1.13 | 0.012861 | 0.036737 |
GO:0043229 | intracellular organelle | 5.95% (11/185) | 1.13 | 0.012861 | 0.036737 |
GO:0060090 | molecular adaptor activity | 1.08% (2/185) | 3.53 | 0.013028 | 0.036872 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.08% (2/185) | 3.53 | 0.013028 | 0.036872 |
GO:0046467 | membrane lipid biosynthetic process | 1.08% (2/185) | 3.44 | 0.014631 | 0.041221 |
GO:0022853 | active monoatomic ion transmembrane transporter activity | 1.62% (3/185) | 2.54 | 0.015066 | 0.042253 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 3.78% (7/185) | 1.45 | 0.015211 | 0.042466 |
GO:0008352 | katanin complex | 0.54% (1/185) | 5.94 | 0.016174 | 0.043015 |
GO:0006898 | receptor-mediated endocytosis | 0.54% (1/185) | 5.94 | 0.016174 | 0.043015 |
GO:0043138 | 3'-5' DNA helicase activity | 0.54% (1/185) | 5.94 | 0.016174 | 0.043015 |
GO:0030122 | AP-2 adaptor complex | 0.54% (1/185) | 5.94 | 0.016174 | 0.043015 |
GO:0003855 | 3-dehydroquinate dehydratase activity | 0.54% (1/185) | 5.94 | 0.016174 | 0.043015 |
GO:0015377 | chloride:monoatomic cation symporter activity | 0.54% (1/185) | 5.94 | 0.016174 | 0.043015 |
GO:0015296 | monoatomic anion:monoatomic cation symporter activity | 0.54% (1/185) | 5.94 | 0.016174 | 0.043015 |
GO:0072583 | clathrin-dependent endocytosis | 0.54% (1/185) | 5.94 | 0.016174 | 0.043015 |
GO:0031145 | anaphase-promoting complex-dependent catabolic process | 0.54% (1/185) | 5.94 | 0.016174 | 0.043015 |
GO:0004764 | shikimate 3-dehydrogenase (NADP+) activity | 0.54% (1/185) | 5.94 | 0.016174 | 0.043015 |
GO:0140101 | catalytic activity, acting on a tRNA | 1.62% (3/185) | 2.51 | 0.015923 | 0.044255 |
GO:0022402 | cell cycle process | 1.62% (3/185) | 2.48 | 0.016807 | 0.044507 |
GO:0050789 | regulation of biological process | 10.27% (19/185) | 0.76 | 0.017003 | 0.044832 |
GO:0008017 | microtubule binding | 1.62% (3/185) | 2.47 | 0.01726 | 0.045124 |
GO:0006650 | glycerophospholipid metabolic process | 1.62% (3/185) | 2.47 | 0.01726 | 0.045124 |
GO:0004540 | RNA nuclease activity | 1.62% (3/185) | 2.45 | 0.017719 | 0.046128 |
GO:0090114 | COPII-coated vesicle budding | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:1905393 | plant organ formation | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0015294 | solute:monoatomic cation symporter activity | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0016423 | tRNA (guanine) methyltransferase activity | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0006474 | N-terminal protein amino acid acetylation | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0031414 | N-terminal protein acetyltransferase complex | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0006687 | glycosphingolipid metabolic process | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0106018 | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0052866 | phosphatidylinositol phosphate phosphatase activity | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0046477 | glycosylceramide catabolic process | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0006680 | glucosylceramide catabolic process | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0006678 | glucosylceramide metabolic process | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0006677 | glycosylceramide metabolic process | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0004348 | glucosylceramidase activity | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0006900 | vesicle budding from membrane | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0046479 | glycosphingolipid catabolic process | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0019377 | glycolipid catabolic process | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0031490 | chromatin DNA binding | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0006419 | alanyl-tRNA aminoacylation | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0044770 | cell cycle phase transition | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0044772 | mitotic cell cycle phase transition | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0046695 | SLIK (SAGA-like) complex | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0000082 | G1/S transition of mitotic cell cycle | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0044843 | cell cycle G1/S phase transition | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0004813 | alanine-tRNA ligase activity | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0006428 | isoleucyl-tRNA aminoacylation | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0004822 | isoleucine-tRNA ligase activity | 0.54% (1/185) | 5.53 | 0.021508 | 0.048968 |
GO:0030163 | protein catabolic process | 1.08% (2/185) | 3.14 | 0.021831 | 0.049339 |
GO:0065007 | biological regulation | 10.27% (19/185) | 0.73 | 0.021785 | 0.049416 |
GO:0042578 | phosphoric ester hydrolase activity | 2.7% (5/185) | 1.65 | 0.022129 | 0.049831 |